7 Results for "

SW1990 cells

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "SW1990 cells" in MCE Product Catalog:

Cat. No.: HY-144661
CAS No.: 2765254-39-3
Purity:  99.39%
Target:  

Ras Apoptosis

Research Areas:  

Cancer

KRAS G12D inhibitor 14 is a potent KRAS G12D inhibitor with a KD of 33 nM for binding to KRAS G12D protein. KRAS G12D inhibitor 14 decreases the active form of KRAS G12D (KRAS G12D-GTP) but not KRAS G13D .
loading...
    loading...
Cat. No.: HY-135770
CAS No.: 1360606-85-4
9-Dehydroxyeurotinone is an anthraquinone derivative that can be found in Eurotium rubrum. 9-Dehydroxyeurotinone shows cytotoxicity with an IC50 value of 25 µg/mL for SW1990 cells .
loading...
    loading...
Cat. No.: HY-155303
CAS No.: 2978517-43-8
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

DCLK1-IN-2 (compound I-5) is a potent DCLK1 inhibitor with an IC50 of 171.3  nM. DCLK1-IN-2 shows remarkable antiproliferative effects on SW1990 cell lines (IC50 of 0.6 μM) and in vivo antitumor potency .
loading...
    loading...
Cat. No.: HY-N12147
CAS No.: 1841524-78-4
Cannogenol 3-O-β-gentiobiosyl-(1→4)-α-L-thevetoside (Compound 12) is a cardiac glycoside that can be isolated from seeds of Thevetia peruvian. Cannogenol 3-O-β-gentiobiosyl-(1→4)-α-L-thevetoside shows cytotoxicity against SW1990 and MGC-803 cells (IC50: 9.52 and 7.70 μM) .
loading...
    loading...
Cat. No.: HY-144338
CAS No.: 2758117-74-5
PARP1/BRD4-IN-1 is a potent and high selective PARP1/BRD4 inhibitor (IC50s of 49 and 202 nM in PARP1 and BRD4, respectively). PARP1/BRD4-IN-1 represses the expression and activity of PARP1 and BRD4 to synergistically inhibit the malignant growth of pancreatic cancer cells .
loading...
    loading...
Cat. No.: HY-182749
Target:  

Ras Akt Raf ERK

Research Areas:  

Cancer

KRAS-IN-58 is a KRAS inhibitor with a IC50 of 0.223 μM against KRAS G12D. KRAS-IN-58 binds to KRAS G12C and KRAS G12D proteins, and reduces the levels of phosphorylated Raf1, AKT and ERK in pancreatic cancer cells. KRAS-IN-58 can be used for the research of pancreatic cancer .
loading...
    loading...
Cat. No.: HY-180200
CAS No.: 3032602-44-8
Target:  

Ras ERK

Research Areas:  

Cancer

RNK08954 is an orally active KRASG12D inhibitor with a Kd of 0.0395 nM. RNK08954 selectively binds the inactive GDP-bound KRASG12D form, suppresses downstream KRAS-mediated signaling pathways p-ERK1/2 experssion. RNK08954 inhibits KRASG12D-mutant cell proliferation, induces G0-G1 cell cycle arrest, and inhibits tumor growth in mouse xenograft models. RNK08954 can be used for the research of non-small cell lung cancer, pancreatic ductal adenocarcinoma .
loading...
    loading...